Free Daily Podcast Summary
Psychopharmacology and Psychiatry Updates: Daily Summaries Delivered
by Psychopharmacology Institute
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 4 days ago9 min
SSRI Dosing for OCD: Beyond FDA Guidelines
Faculty: Robert Hudak, M.D. Host: Flavio Guzmán, M.D. Learn more about our memberships here Earn 1.25 CME: SSRI Dosing for OCD: Beyond FDA Guidelines Treatment-Resistant OCD: From SSRIs to Augmentation
- 1 weeks ago10 min
Trazodone for Insomnia and Comorbid Depression
Faculty: Paul Zarkowski, M.D. Host: Flavio Guzmán, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 85 Trazodone for Insomnia and Comorbid Depression: Are the AASM Guidelines Relevant?
- 2 weeks ago8 min
Antipsychotics, Prolactin, and Sexual Side Effects
In this episode, we explore why antipsychotics cause hyperprolactinemia and sexual side effects, a leading reason patients quietly stop treatment. Dr. Oliver Freudenreich breaks down which medications carry the highest risk, the long-term health implications, and practical strategies for monitoring, switching, or augmenting therapy. Faculty: Oliver Freudenreich, M.D., F.A.C.L.P. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Managing Side Effects of Antipsychotics: What Every Psychiatrist Should Know Managing Hyperprolactinemia and Sexual Side Effects from Antipsychotic Use
- 2 weeks ago12 min
EMERGENT-5: Cobenfy and Treatment Durability
In this episode, we sit down with Dr. Oliver Freudenreich to unpack EMERGENT-5, the year-long trial tracking Cobenfy's real-world durability and safety in schizophrenia. We explore whether early symptom gains hold up over time, what side effects persist, and why blood pressure monitoring now deserves a permanent spot on your checklist. Faculty: Oliver Freudenreich, M.D., F.A.C.L.P. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CME: Quick Take Vol. 85 Xanomeline-Trospium Long-Term: Does Efficacy and Safety Hold Up After One Year?
- 3 weeks ago14 min
Antipsychotics and Weight Gain
In this episode, we sit down with Dr. Oliver Freudenreich to unpack antipsychotic-induced weight gain — why it happens, which medications carry the highest risk, and how to build a proactive ABC strategy using switching, metformin, and emerging GLP-1 agonists to protect your patients' metabolic health. Faculty: Oliver Freudenreich, M.D., F.A.C.L.P. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Managing Side Effects of Antipsychotics: What Every Psychiatrist Should Know Antipsychotic-Induced Weight Gain: Prevention and Management
- 4 weeks ago12 min
EPA vs. DHA: Fish Oil and Treatment-Resistant Depression
In this episode, we explore whether EPA, a specific omega-3 fatty acid, can help patients with treatment-resistant depression. Dr. Derick Vergne breaks down the clinical evidence, dosing, and the anti-inflammatory mechanisms that may explain why EPA outperforms DHA in easing stubborn depressive symptoms. Faculty: Derick E. Vergne, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CMEs: Quick Take Vol. 84 Eicosapentaenoic Acid: Effective as Adjunctive for TRD?
- Sep 3, 202610 min
AUD Medications and Hepatic Safety
In this episode, we explore how liver status shapes medication choice for alcohol use disorder. Dr. Kevin Sevarino breaks down a practical algorithm for selecting between naltrexone, acamprosate, disulfiram, and other options, tailored to hepatic function, from early liver disease through decompensated cirrhosis. Faculty: Kevin A. Sevarino, M.D.C.M., Ph.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Pharmacotherapy of Alcohol Use Disorder Alcohol Use Disorder Algorithm: Medication Selection Based on Liver Status
- Aug 29, 202615 min
GLP-1 Agonists in Serious Mental Illness: Current Evidence
In this episode, we explore whether GLP-1 agonists like semaglutide can tackle the metabolic toll of antipsychotics in schizophrenia. Can a drug famous for celebrity weight loss actually protect our most vulnerable psychiatric patients from diabetes and obesity before the damage is done? Faculty: Oliver Freudenreich, M.D., F.A.C.L.P. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 84 GLP-1s in Schizophrenia: Should Semaglutide Be Added for Metabolic Management?
Get Psychopharmacology and Psychiatry Updates summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Psychiatry & Psychotherapy Podcast
Explores psychiatry and psychotherapy through interviews with experts, trainees, and individuals sharing lived mental health experiences.
The Curbsiders Internal Medicine Podcast
Expert-led internal medicine discussions with clinical insights and humor for primary care and hospital medicine providers.
PSYCHOACTIVE
Explores humanity's complex relationship with drugs through conversations with users, experts, and critics.
Frankly Speaking About Family Medicine
Discusses current topics and developments in primary care and family medicine.
Speaking of Psychology
Explores recent psychological research and its applications to daily life.
In the Interim...
Explores Bayesian statistics and adaptive clinical trial designs in medical research with insights from industry experts.
Pharmacy Podcast Network
A podcast network featuring dozens of shows on pharmacy practice, policy, and innovation, with interviews across clinical and industry specialties.
The Peter Attia Drive
Conversations with experts on health, longevity, performance, and critical thinking led by physician Peter Attia.
Red Pill Your Healthcast
Two healthcare providers discuss overlooked health issues and empower listeners to make informed decisions for their families.
Health Optimization Medicine Podcast
Experts discuss science-based strategies for health optimization, performance, and human potential through targeted interventions.
Therapy in a Nutshell
A therapist breaks down research-backed mental health techniques into short, practical lessons for managing anxiety and depression.
Health Discovered
Doctors explore surprising stories to uncover insights about health and well-being.
About Psychopharmacology and Psychiatry Updates
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Psychopharmacology and Psychiatry Updates in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Psychopharmacology and Psychiatry Updates daily summary?
It's a free AI-powered email that summarizes new episodes of Psychopharmacology and Psychiatry Updates as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Psychopharmacology and Psychiatry Updates podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Psychopharmacology and Psychiatry Updates product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Psychopharmacology Institute.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Psychopharmacology and Psychiatry Updates release new episodes?
Psychopharmacology and Psychiatry Updates publishes 2x weekly. Our AI generates a summary within hours of each new episode.
What topics does Psychopharmacology and Psychiatry Updates cover?
Psychopharmacology and Psychiatry Updates covers topics including Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Psychopharmacology and Psychiatry Updates summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.